372
Participants
Start Date
September 8, 2020
Primary Completion Date
August 11, 2024
Study Completion Date
August 11, 2024
Wearable activity sensor
Caregivers and patients in both arms of the study will have a Fitbit wearable activity sensor to track activity and sleep.
Roadmap 2.0 information system
Caregivers and patients download the Roadmap 2.0 app on their mobile phones or tablets
Survey administration
Caregivers and patients will be asked to respond to survey questions at 3 timepoints.
Roadmap 2.0 information system with Positive Activities
Caregivers and patients download the Roadmap 2.0 app on their mobile phones. Caregivers and patients will be instructed on how to operate Roadmap 1.0 on an iPad (inpatient only) and Roadmap 2.0 on a mobile phone (inpatient and outpatient). Caregivers download the Positive Activities app onto their mobile phone to use freely throughout inpatient and outpatient (through day 120 post-transplant). Caregiver may also use an electronic tablet provided by the study team during the patient's hospital stay.
University of Michigan Rogel Cancer Center, Ann Arbor
Oregon Health & Science University, Portland
Department of Health and Human Services
FED
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Michigan Rogel Cancer Center
OTHER